2024-20643. Organ Procurement and Transplantation: Implementation of the HIV Organ Policy Equity (HOPE) Act

Table 1—Summary of Impacts of the Proposed Rule

[Millions of constant 2023 dollars

Category	Primary estimate	Low estimate	High estimate	Dollar year or unit	Discount rate (%)	Time horizon	Notes
BENEFITS:
Annualized monetized benefits	$900	$561	$1,261	2023	2	2025-2034	Increased life expectancy for organ transplant recipients; improved quality of life for kidney transplant recipients; time savings from fewer kidney dialysis visits.
Annualized quantified, but non-monetized, benefits	147	129	166	People affected	2	2025-2034	Improved quality of life for liver transplant recipients.
Unquantified benefits						2025-2034	Time savings for caregivers; cost savings related to removing the research and institutional review board requirements.
COSTS:
Annualized monetized costs	$154	$134	$174	2023	2	2025-2034	Net costs associated with organ transplants; costs associated with organ transplant centers reading and understanding the rule, reviewing policies and procedures, and training staff.
TRANSFERS:
Annualized monetized transfers	$31	$24	$39	2023	2	2025-2034	Shift in expenditures associated with kidney dialysis to expenditures associated with kidney transplantation.
NET BENEFITS:
Annualized monetized net benefits	$746	$412	$1,101	2023	2	2025-2034
Note: primary, low, and high estimates correspond to the mean, 5th percentile, and 95th percentile of the outcomes of a Monte Carlo simulation.